Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;102:546-553
Published online before print January 17, 2008, doi: 10.1161/CIRCRESAHA.107.161653
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
102/5/546    most recent
CIRCRESAHA.107.161653v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Han, J. W.
Right arrow Articles by Weyand, C. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, J. W.
Right arrow Articles by Weyand, C. M.
Related Collections
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Other Vascular biology
Right arrow Pathophysiology
Right arrow Cell biology/structural biology
Right arrow Cell signalling/signal transduction
(Circulation Research. 2008;102:546.)
© 2008 American Heart Association, Inc.


Molecular Medicine

Vessel Wall–Embedded Dendritic Cells Induce T-Cell Autoreactivity and Initiate Vascular Inflammation

Ji W. Han*, Kazunori Shimada*, Wei Ma-Krupa, Tiffany L. Johnson, Robert M. Nerem, Jörg J. Goronzy, Cornelia M. Weyand

From the Kathleen B. and Mason I. Lowance Center for Human Immunology (J.W.H., K.S., W.M.-K., J.J.G., C.M.W.), Department of Medicine, Emory University School of Medicine, Atlanta, Ga; and Parker H. Petit Institute for Bioengineering and Bioscience (T.L.J., R.M.N.), Georgia Institute of Technology, Atlanta.

Correspondence to Cornelia M. Weyand, MD, PhD, Lowance Center for Human Immunology, Emory University School of Medicine, Room 1003 WMRB, 101 Woodruff Cir, Atlanta, GA 30322. E-mail cweyand{at}emory.edu

Human medium-sized and large arteries are targeted by inflammation with innate and adaptive immune responses occurring within the unique microspace of the vessel wall. How 3D spatial arrangements influence immune recognition and cellular response thresholds and which cell populations sense immunoactivating ligands and function as antigen-presenting cells are incompletely understood. To mimic the 3D context of human arteries, bioartificial arteries were engineered from collagen type I matrix, human vascular smooth muscle cells (VSMCs), and human endothelial cells and populated with cells implicated in antigen presentation and T-cell stimulation, including monocytes, macrophages, and myeloid dendritic cells (DCs). Responsiveness of wall-embedded antigen-presenting cells was probed with the Toll-like receptor ligand lipopolysaccharide, and inflammation was initiated by adding autologous CD4+ T cells. DCs colonized the outermost VSMC layer, recapitulating their positioning at the media–adventitia border of normal arteries. Wall-embedded DCs responded to the microbial product lipopolysaccharide by entering the maturation program and upregulating the costimulatory ligand CD86. Activated DCs effectively stimulated autologous CD4 T cells, which produced the proinflammatory cytokine interferon-{gamma} and infiltrated deeply into the VSMC layer, causing matrix damage. Lipopolysaccharide-triggered macrophages were significantly less efficacious in recruiting T cells and promoting T-cell stimulation. CD14+ monocytes, even when preactivated, failed to support initial steps of vascular wall inflammation. Innate immune cells, including monocytes, macrophages, and DCs, display differential functions in the vessel wall. DCs are superior in sensing pathogen-derived motifs and are highly efficient in breaking T-cell tolerance, guiding T cells toward proinflammatory and tissue-invasive behavior.


Key Words: inflammation • bioengineered vessel • arteries • immune system • interleukins • dendritic cells • Toll-like receptors